Patents by Inventor Matthew David Bartolowits

Matthew David Bartolowits has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors for proliferating cell nuclear antigen and uses
    Patent number: 11400130
    Abstract: The present invention relates to series of compounds as an inhibitor targeting Proliferating Cell Nuclear Antigen (PCNA). Pharmaceutical compositions of those compounds and methods of using them in the treatment of cancer are within the scope of this disclosure.
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: August 2, 2022
    Assignee: Purdue Research Foundation
    Inventors: Vincent Jo Davisson, Matthew David Bartolowits, Jonathon Michael Gast
  • INHIBITORS FOR PROLIFERATING CELL NUCLEAR ANTIGEN AND USES
    Publication number: 20220160813
    Abstract: The present invention relates to series of compounds as an inhibitor targeting Proliferating Cell Nuclear Antigen (PCNA). Pharmaceutical compositions of those compounds and methods of using them in the treatment of cancer are within the scope of this disclosure.
    Type: Application
    Filed: August 12, 2020
    Publication date: May 26, 2022
    Applicant: Purdue Research Foundation
    Inventors: Vincent Jo Davisson, Matthew David Bartolowits, Jonathon Michael Gast
  • Inhibitors for proliferating cell nuclear antigen and uses
    Patent number: 10758588
    Abstract: The present invention relates to series of compounds as an inhibitor targeting Proliferating Cell Nuclear Antigen (PCNA). Pharmaceutical compositions of those compounds and methods of using them in the treatment of cancer are within the scope of this disclosure.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: September 1, 2020
    Assignee: Purdue Research Foundation
    Inventors: Vincent Jo Davisson, Matthew David Bartolowits, Jonathon Michael Gast
  • INHIBITORS FOR PROLIFERATING CELL NUCLEAR ANTIGEN AND USES
    Publication number: 20180360905
    Abstract: The present invention relates to series of compounds as an inhibitor targeting Proliferating Cell Nuclear Antigen (PCNA). Pharmaceutical compositions of those compounds and methods of using them in the treatment of cancer are within the scope of this disclosure.
    Type: Application
    Filed: December 6, 2016
    Publication date: December 20, 2018
    Applicant: Purdue Research Foundation
    Inventors: Vincent Jo Davisson, Matthew David Bartolowits, Jonathon Michael Gast